Trademark Overview
On Tuesday, September 2, 2025, a trademark application was filed for TOXBAR with the United States Patent and Trademark Office. The USPTO has given the TOXBAR trademark a serial number of 99369694. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, September 2, 2025. This trademark is owned by Athena Medtec Limited. The TOXBAR trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:
Hyaluronic acid based barrier substance injected between prostate and rectum to mitigatethe toxicity effects of radiotherapy treatments of prostate cancer; gel substance injected between prostate and rectum for creating a space between the two for protecting therectum from radiation during prostate cancer radiation treatment; a barrier product tocreate a space between the prostate and the rectal wall to minimise the risk of radiation toxicity impacting on the rectum during radiotherapy treatment for prostate cancer.
Medical devices, namely, synthetic implants in the nature of a hyaluronic acid based barrier substance injected between prostate and rectum to mitigate the toxicity effects of radiotherapy treatments of prostate cancer; Medical devices, namely, synthetic implants in the nature of a gel injected between prostate and rectum for creating a space between the two for protecting the rectum from radiation during prostate cancer radiation treatment; Kits that contain applicators consisting of a needle and a hyaluronic acid based substance for use in medical and surgical procedures; surgical and medical apparatus and instruments; a medical barrier device to create a space between the prostate and the rectal wall to minimise the risk of radiation toxicity impacting on the rectum during radiotherapy treatment for prostate cancer.
